Prognostic significance of the number of positive lymph nodes in women with T1-2N1 breast cancer treated with mastectomy: Should patients with 1, 2, and 3 positive lymph nodes be grouped together?

International Journal of Radiation Oncology Biology Physics

Volumn 85, Issue 5, 2013, Pages 1200-1205

  Dai Kubicky, Charlotte ^a   Mongoue Tchokote, Solange ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAUSE-SPECIFIC SURVIVAL; COX PROPORTIONAL HAZARD MODEL; KAPLAN-MEIER METHOD; METHODS AND MATERIALS; MULTI VARIATE ANALYSIS; POSITIVE LYMPH NODES; PROGESTERONE RECEPTOR; PROGNOSTIC SIGNIFICANCE;

BODY FLUIDS; DIAGNOSIS; DISEASES; MULTIVARIANT ANALYSIS; PATIENT MONITORING;

PATIENT TREATMENT;

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CAUSE SPECIFIC SURVIVAL; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; LYMPH NODE; MAJOR CLINICAL STUDY; MASTECTOMY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE; TUMOR VOLUME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LINEAR MODELS; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; SEER PROGRAM; SURVIVAL ANALYSIS; TUMOR BURDEN; YOUNG ADULT;

EID: 84875233041     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.11.005     Document Type: Article

References (17)

1. L.J. Pierce The use of radiotherapy after mastectomy: A review of the literature J Clin Oncol 23 2005 1706 1717
2. A. Recht, S.B. Edge, and L.J. Solin Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology J Clin Oncol 19 5 2001 1539 1569
3. M. Overgaard, H.M. Nielsen, and J. Overgaard Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials Radiother Oncol 82 2007 247 253
4. M. Clarke, R. Collins, and S. Darby Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Lancet 366 9503 2005 2087 2106
5. T.J. Whelan, I. Olivotto, and I. Ackerman NCIC CTG MA.20: An intergroup trial of regional nodal irradiation in early breast cancer J Clin Oncol 29 15 Suppl 2011 LAB 1003
6. R.R. German, A.K. Fink, and M. Heron The accuracy of cancer mortality statistics based on death certificates in the United States Cancer Epidemiol 35 2 2011 126 131
7. J.L. Lund, L.C. Harlan, and K.R. Yabroff Should cause of death from the death certificate be used to examine cancer-specific survival? A study of patients with distant stage disease Cancer Invest 28 7 2010 758 764
8. N. Howlader, L.A. Ries, and A.B. Mariotto Improved estimates of cancer-specific survival rates from population-based data J Natl Cancer Inst 102 20 2010 1584 1598
9. B.D. Smith, G.L. Smith, and B.G. Haffty Postmastectomy radiation and mortality in women with T1-2 node-positive breast cancer J Clin Oncol 23 2005 1409 1419
10. S.L. Chen, F.M. Hoehne, and A.E. Giuliano The prognostic significance of micrometastases in breast cancer: A SEER population-based analysis Ann Surg Oncol 14 2007 3378 3384
11. V. Vinh-Hung, and G. Storme No nodal cutoff in node-positive breast cancer women treated with mastectomy Breast Cancer Res Treat 98 2006 173 178
12. P. Tai, E. Yu, and K. Joseph Prognostic significance of number of positive nodes: A long-term study of one to two nodes versus three nodes in breast cancer patients Int J Radiat Oncol Biol Phys 77 2010 180 187
13. R. Jagsi, P. Abrahamse, and S.T. Hawley Underascertainment of radiotherapy receipt in Surveillance, Epidemiology, and End Results registry data Cancer 118 2 2012 333 341
14. T. Sorlie, C.M. Perou, and R. Tibshirani Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci U S A 98 19 2001 10869 10874
15. B.G. Haffty, and T.A. Buchholz Molecular predictors of locoregional recurrence in breast cancer: Ready for prime time? J Clin Oncol 28 2010 1627 1629
16. K.D. Voduc, M.C. Cheang, and S. Tyldesley Breast cancer subtypes and the risk of local and regional relapse J Clin Oncol 28 10 2010 1684 1691
17. E.P. Mamounas, G. Tang, and B. Fisher Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20 J Clin Oncol 28 10 2010 1677 1683